Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- JPMorgan Bringing Back Employees to Work From Office 446 views
- Spotify Records 20% Increase in Paid Subscribers in the Second Quarter 330 views
- Apple Employee Claims to Have Been Dismissed After Leading Movement Against Harassment 316 views
- Solar Car Company Sono Motors Files For United States IPO 246 views
- Ferari Poaches New CEO From Tech Industry 237 views